Treatment with bevacizumab and irinotecan in patients with recurrent or refractory high grade glioma after conventional treatment.

Registry ID

EUCTR2009-012582-64

Source registry

EUCTR

Status

Completed

Phase

PHASE2

Sponsor

POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI

Start date

2009-07-29

Last update

2026-08-16

Conditions

• high grade glioma

Summary

To assess the rate of objective confirmed tumor response of bevacizumab in combination with irinotecan in patients with recurrent or refractory high grade glioma after conventional treatment

Locations

• , , Italy

View on source registry